Plurihormonality of pituitary adenomas in light of immunohistochemical studies

Endokrynologia Polska

Volumn 61, Issue 1, 2010, Pages 63-66

  Pawlikowski, Marek ^a   Kunert Radek, Jolanta ^a   Radek, MacIej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Immunohistochemistry; Pituitary adenomas; Plurihormonality; Tumour recurrence

Indexed keywords

CORTICOTROPIN; KI 67 ANTIGEN;

ACROMEGALY; ACTH SECRETING ADENOMA; ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; PLURIHORMONALITY; RECURRENCE RISK; TUMOR RECURRENCE;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; FOLLICLE STIMULATING HORMONE; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUTEINIZING HORMONE; NEOPLASM RECURRENCE, LOCAL; PITUITARY ACTH HYPERSECRETION; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROLACTIN;

EID: 77950525632     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumors World Health Organization, International Histological Classification of Tumors, Springer 2004, 16-22.
2. 2.. Ikeda H, Yoshimoto, Yandell DW. Hormone production and c-myc protein labeling in plurihormonal pituitary adenomas. Endocr Pathol 1994; 5: 162-168.
3. Matsuno A, Teramoto A, Takekoshi S et al. HGH, PRL and ACTH gene expression in clinically nonfunctioning adenomas detected with nonisotopic in situ hybridization method. Endocr Pathol 1995; 6: 13-20.
4. Scheithauer BW, Kovacs K, Horvath E. The adenohypophysis In: Lechago J., Gould VE (eds). Bloodworth Endocrine Pathology. Williams and Wilkins, Baltimore 1997: 85-152.
5. Ho DM, Hsu CY, Ting LT et al. Plurihormonal pituitary adenomas: immunostaining of all hormones is mandatory for correct classification Hi-stopathology 2001; 39: 310-319.
6. Kunert-Radek J, Radek A, Gruszka A et al. Immunohistochemical investigation of clinically nonfunctioning pituitary tumors as a prognostic factor of tumor recurrence Proceedings, 12th Int Congress of Endocrinology, Lisbon 31.VIII-4.IX.2004, Medimond.
7. Salehi F, Cohen S, Syro LV et al. Plurihormonality in pituitary adenomas associated with acromegaly Endocr Pathol 2006; 17: 291-296. (Pubitemid 46279677)
8. Coculescu M, Badiu C, Galoiu S et al. Evolution under complex therapy of acromegaly due to a pituitary plurihormonal adenoma with colocalization of GH and FSH Acta Endocrinol 2006; 2: 337-348.
9. Zielińska M, Zielińska A, Kunert-Radek J et al. Immunohistochemical electron microscope study on coexistence of hormones in pituitary adenomas Endokrynologia Polska 2008; 59 (Suppl. A): P2-46, 62-63.
10. Turner HE, Wass JA Are markers of proliferation valuable in the histological assessment of pituitary tumours? Pituitary 1999; 1: 147-151.
11. Pawlikowski M, Gruszka A, Kurnatowska I et al. Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma Folia Histochem Cytobiol 2006; 44: 37-41. (Pubitemid 43224825)
12. Desai B, Bunin M, Nott CA, Geddes JF, Lamb EJ, Wood DF et al. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours - an in vitro and immunohistochemical study Eur J Endocrinol 1995; 133: 25-32.
13. Bradley KJ, Wass JA, Turner HE. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but not recur more frequently Clin Endocrinol 2003; 58: 59-64.